Near infrared fluorescent biosensors for steroid hormones

US2020348291A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020348291-A1
Application numberUS-202016866091-A
CountryUS
Kind codeA1
Filing dateMay 4, 2020
Priority dateMay 5, 2019
Publication dateNov 5, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Corona Phase Molecular Recognition (CoPhMoRe) utilizing a template heteropolymer adsorbed onto and templated by a nanoparticle surface to recognize a specific target analyte can be used for macromolecular analytes, including proteins.

First claim

Opening claim text (preview).

What is claimed is: 1 . A composition, comprising: a complex, wherein the complex includes: a nanostructure; and a polymer, the polymer adsorbed on the nanostructure and the polymer being free from selective binding to an analyte in the absence of being adsorbed on the nanostructure, wherein the polymer is a heteropolymer including a hydrophobic region and a hydrophilic region and the polymer includes a template moiety; and a selective binding site associated with the complex, the selectivity of the selective binding site being dependent on the template moiety. 2 . The composition of claim 1 , wherein the nanostructure is a photoluminescent nanostructure. 3 . The composition of claim 2 , wherein the photoluminescent nanostructure is a nanotube, a carbon nanotube, or a single-walled carbon nanotube. 4 . The composition of claim 1 , wherein the polymer includes a polystyrene. 5 . The composition of claim 4 , wherein the polymer includes a polyacrylate. 6 . The composition of claim 1 , wherein the polymer is a polyacrylate-polystyrene copolymer. 7 . The composition of claim 1 , wherein the polymer is covalently bonded to one or more of the template moiety. 8 . The composition of claim 8 , wherein the template moiety includes a steroid moiety. 9 . The composition of claim 1 , wherein the polymer has the structure: wherein n is 1 to 500, m is an integer from 0 to 500, and k is an integer from 1 to 500; T is a template moiety; A is a hydrophilic moiety; and Q is a group that associates with the nanostructure. 10 . The composition of claim 9 , wherein Q is an aromatic group. 11 . The composition of claim 1 , wherein the template is a cortisol, testosterone, dehydroepiandrosterone (DHEA), pregnenolone, estradiol, prednisone, corticosterone, progesterone, cortisone, aldosterone or prednisolone moiety. 12 . The composition of claim 1 , wherein the analyte is cortisol, testosterone, dehydroepiandrosterone (DHEA), pregnenolone, estradiol, prednisone, corticosterone, progesterone, cortisone, aldosterone or prednisolone. 13 . A sensor including a matrix and the composition of claim 1 suspended in the matrix. 14 . A method for analyzing a sample for an analyte, comprising: providing a composition of claim 1 ; exposing the composition to a sample; monitoring a property of the composition; and determining a presence of an analyte in the sample based on the property. 15 . The method of claim 14 , wherein the sample includes a gas, a liquid or a solid. 16 . The method of claim 14 , wherein the sample is a biological fluid. 17 . The method of claim 14 , wherein the property is an emission, emission intensity, or an emission wavelength. 18 . The method of claim 14 , wherein exposing the composition to a sample includes inserting the composition into an animal, a plant, or a fungus. 19 . The method of claim 14 , wherein exposing the composition to a sample includes incubating the composition with a microorganism, a virus, a cell line, or an in vitro model system. 20 . The method of claim 14 , wherein determining the presence of an analyte includes determining the absence of the analyte, or determining the concentration of the analyte. 21 . The method of claim 14 , wherein monitoring a property of the composition includes creating an image. 22 . A method of making a composition including: templating a composition that selective binds an analyte. 23 . The method of claim 22 , wherein templating includes contacting a nanostructure, and a polymer, the polymer adsorbed on the nanostructure and the polymer being free from selective binding to an analyte in the absence of being adsorbed on the nanostructure, wherein the polymer is a heteropolymer including a hydrophobic region and a hydrophilic region and the polymer includes a template moiety. 24 . A system comprising: the composition claim 1 ; an electromagnetic radiation source having an excitation wavelength directed at the composition; and a detector configured to receive an emission wavelength from the composition.

Assignees

Inventors

Classifications

  • Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

  • the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle · CPC title

  • Optical sensor arrangements for performing transmission measurements on body tissue · CPC title

  • invasive, e.g. introduced into the body by a catheter · CPC title

  • Steroid hormones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020348291A1 cover?
Corona Phase Molecular Recognition (CoPhMoRe) utilizing a template heteropolymer adsorbed onto and templated by a nanoparticle surface to recognize a specific target analyte can be used for macromolecular analytes, including proteins.
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification G01N33/5436. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Nov 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).